Leptin, adiponectin, and ghrelin dysregulation in chronic kidney disease

被引:28
作者
Guebre-Egziabher, F
Bernhard, J
Geelen, G
Malvoisin, E
Hadj-Aissa, A
Fouque, D [1 ]
机构
[1] Hop Edouard Herriot, Dept Nephrol, F-69437 Lyon 03, France
[2] Univ Lyon 1, Unite Rech JE 2411, F-69365 Lyon, France
[3] Hop Edouard Herriot, Lab Explorat Fonctionnelles Renales & Metab, F-69437 Lyon 03, France
[4] Hop Edouard Herriot, Lab Radioimmunoanal, F-69437 Lyon 03, France
关键词
D O I
10.1053/j.jrn.2004.09.015
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 [营养与食品卫生学];
摘要
In the past 10 years, 3 new metabolic compounds, leptin, adiponectin, and ghrelin, involved in energy metabolism, body composition, and appetite regulation, have been discovered. We have assessed their characteristics in 46 patients with stage 3 to 4 chronic kidney disease to evaluate the role of decreased renal function in the abnormal handling reported in more severe end-stage renal disease patients. In addition to the usual correlations with body mass index and body fat mass, the results show unexpected positive correlations between leptin and insulin, leptin and adiponectin, a weak inverse relationship between adiponectin and glomerular filtration rate, and no influence of C-reactive protein on either leptin or adiponectin in these noninflamed patients. Serum ghrelin was inversely correlated with body mass index and with glomerular filtration rate as measured by inulin clearance. Thus, ghrelin and leptin, 2 antagonist signals for energy balance, both seem to increase when glomerular filtration rate is reduced, potentially neutralizing their respective biologic effects in severe renal insufficiency. (C) 2005 by the National Kidney Foundation, Inc.
引用
收藏
页码:116 / 120
页数:5
相关论文
共 27 条
[1]
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[2]
Associations between plasma ghrelin levels and body composition in end-stage renal disease:: a longitudinal study [J].
Ayala, ER ;
Pecoits, R ;
Heimbürger, O ;
Lindholm, B ;
Nordfors, L ;
Stenvinkel, P .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (02) :421-426
[3]
Hyperleptinemia prevents increased plasma ghrelin concentration during short-term moderate caloric restriction in rats [J].
Barazzoni, R ;
Zanetti, M ;
Stebel, M ;
Biolo, G ;
Cattin, L ;
Guarnieri, G .
GASTROENTEROLOGY, 2003, 124 (05) :1188-1192
[4]
Inhibition of food intake in obese subjects by peptide YY3-36 [J].
Batterham, RL ;
Cohen, MA ;
Ellis, SM ;
Le Roux, CW ;
Withers, DJ ;
Frost, GS ;
Ghatei, MA ;
Bloom, SR .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (10) :941-948
[5]
Serum immunoreactive leptin concentrations in normal-weight and obese humans [J].
Considine, RV ;
Sinha, MK ;
Heiman, ML ;
Kriauciunas, A ;
Stephens, TW ;
Nyce, MR ;
Ohannesian, JP ;
Marco, CC ;
McKee, LJ ;
Bauer, TL ;
Caro, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :292-295
[6]
DURNIN DJ, 1974, BR J NUTR, V32, P77
[7]
FOUQUE D, 2001, J AM SOC NEPHROL, V12, P202
[8]
Leptin:: physiology and pathophysiology [J].
Frühbeck, G ;
Jebb, SA ;
Prentice, AM .
CLINICAL PHYSIOLOGY, 1998, 18 (05) :399-419
[9]
Evaluation of the comparability of commercial ghrelin assays [J].
Gröschl, M ;
Uhr, M ;
Kraus, T .
CLINICAL CHEMISTRY, 2004, 50 (02) :457-458
[10]
GUEBREEGZIABHER F, 2004, IN PRESS NEPHROL DIL